Mehmet Kocoglu

13PUBLICATIONS
97CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 31, 2026
Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation.

|Jun 03, 2026
Arlocabtagene autoleucel: a GPRC5D-targeted CAR T-cell therapy for heavily pretreated relapsed/refractory multiple myeloma.

|May 12, 2026
Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.

|Aug 28, 2025
Safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia.

Gliceida M Galarza Fortuna, Lauren Peres, Elena Nazarenko

|Jul 29, 2025
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.

Edward Richardson, Clifton C Mo, Eleonora Calabretta

|Feb 18, 2025
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

Doris K Hansen, Lauren C Peres, Danai Dima

Pageof 3

Frequent Collaborators

6 joint publications

Surbhi Sidana

6 joint publications

Joseph P McGuirk

6 joint publications

Jack Khouri

6 joint publications

Douglas W Sborov